AzTrials
AzTrials

Chronic Musculoskeletal PainCRYONICNCT07289984

Correlation Between Diagnostic Nerve Block Response and Cryoneurolysis Outcome in Chronic Musculoskeletal Disorders

A study testing cryoablation in people with Chronic Musculoskeletal Pain and Cryo Analgesia, run by Universitair Ziekenhuis Brussel.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

The clinical study is titled the CRYONIC PROTOCOL, which stands for Cryotherapy for Neurolysis In Chronic Pain. It is structured as a prospective, multi-cohort observational study. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
cryoablation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
No sites listed yet
Study dates
1 Jul 2026to 1 Aug 2031
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Be over 18 year old
  • Adults (> 18y) with either chronic musculoskeletal pain (> 3 months; average NRS > 5/10) or painful/functionally limiting spasticity
  • Have a clinical stable condition, > 3months
  • Any medications must be maintained on a stable schedule- Able to understand study instructions and provide informed consent (ICF) in French or Dutch.Provide written informed consent

Who cannot join

  • Contraindication to cryoneurolysis such as a diagnosis of cryoglobulinemia, paroxysmal cold haemoglobinuria, cold urticaria, Raynaud's disease, any form of peripheral neuropathy, open and or infected wounds of the affected limb
  • Patient's refusal to give consent to the procedure or to use of their data for research purposes.
  • Ongoing local or systemic infection before the procedure.
  • Predominantly neuropathic pain of the upper extremity as assessed with the Pain Detect questionnaire

About this study

The clinical study is titled the CRYONIC PROTOCOL, which stands for Cryotherapy for Neurolysis In Chronic Pain. It is structured as a prospective, multi-cohort observational study.

Purpose of the Study:

Read more

The overarching purpose of the CRYONIC PROTOCOL study is to assess the Correlation Between Diagnostic Nerve Block Response and Cryoneurolysis Outcome in Chronic Musculoskeletal Disorders. The study focuses on evaluating the effectiveness of ultrasound-guided peripheral nerve cryoneurolysis, a minimally invasive technique that uses extreme cold to induce temporary nerve blocks, for patients with treatment-resistant chronic musculoskeletal pain.

The study also seeks to determine if cryoneurolysis itself leads to meaningful improvements in both pain intensity and functional ability in the included patient cohorts.

Being tested
cryoablation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • cryoablationProcedure or surgery

    Cryoneurolysis

Study groups in NCT07289984
Study groupRoleWhat they receive
Chronic musculoskeletal pain groupExperimentalNot described
Receives: Procedure: cryoablation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Numeric Rating Scale (NRS)

    Correlation between diagnostic nerve bloc and cryoneurolysis

    Numeric Rating Scale (NRS) for pain, range 0-10, higher scores indicate worse pain.

    Measured: 3 months

Secondary outcomes (18)
  1. 2-Minute Walk Test (2MWT)

    A functional test measuring walking endurance (distance walked in 2 minutes); a practical measure of ambulatory capacity

    Two-Minute Walk Test (2MWT), outcome is total distance walked in meters in 2 minutes; there is no fixed minimum or maximum value, and higher distances indicate a better walking capacity.

    Measured: 3 months

  2. Timed Up and Go

    Measures the time taken to stand from a chair, walk 3m, turn, return, and sit, capturing basic mobility, balance, and fall risk

    Timed Up and Go (TUG), outcome is time to complete the task in seconds; there is no fixed minimum or maximum value, and higher times indicate worse mobility and higher fall risk.

    Measured: 3 months

  3. Passive Range of Motion

    Joint angle measurement using a goniometer at the treated joint(s)

    Measured: 3 months

  4. Goal Attainment Scaling

    An individualized, patient-centered goal measure; goals are pre-defined and scored on a 5-point scale

    Goal Attainment Scaling (GAS) is an individualized outcome measure in which patient-specific goals are defined and rated on a 5-point ordinal scale from -2 (much less than expected) to +2 (much more than expected).

    Measured: 3 months

  5. Modified Tardieu Scale

    Assesses spasticity across velocities; considered to have better construct validity for velocity-dependence than MAS

    The Modified Tardieu Scale (MTS) is a clinical measure of spasticity, assessing a muscle's response to passive stretch at different velocities and recording both muscle reaction quality and the angle at which it occurs.

    It uses standardized stretch velocities (V1 very slow, V2 gravity speed, V3 as fast as possible) and scores the quality of muscle reaction from 0 (no resistance) to 5 (joint immobile), while also documenting R1 (angle of catch at fast stretch) and R2 (full passive range at slow stretch) to distinguish dynamic spasticity from fixed contracture

    Measured: 3 months

  6. Modified Ashworth Scale

    Clinician-rated 6-point ordinal scale quantifying muscle tone (resistance to passive movement)

    The Modified Ashworth Scale (MAS) is a 0-4 rating scale (with an additional grade 1+) that describes how much resistance is felt during passive movement of a muscle group. A score of 0 means no increase in muscle tone (normal tone), whereas a score of 4 indicates a rigid limb in flexion or extension. Higher scores on the MAS represent greater spasticity/increased muscle tone and therefore a worse outcome in terms of tone control.

    Measured: 3 months

  7. Oswestry Disability Index (Low Back Pain)

    Measures disability related to low back pain across 10 items focused on daily functioning

    Oswestry Disability Index (ODI) for Low Back Pain, score reported as a percentage from 0-100%, where higher scores indicate worse disability.

    Measured: 3 months

  8. Shoulder Pain and Disability Index (Shoulder)

    A self-administered questionnaire consisting of 13 items (5 for pain, 8 for disability) scored from 0 to 10

    Shoulder Pain and Disability Index (SPADI), total score expressed as a percentage from 0-100%, where higher scores indicate worse shoulder pain and disability.

    Measured: 3 months

  9. Disabilities of the Arm, Shoulder, and Hand (Arm/Shoulder)

    A 30-item questionnaire evaluating upper limb function and symptoms

    Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire, total score expressed from 0-100, where higher scores indicate greater upper-extremity disability and worse function.

    Measured: 3 months

  10. Hip Disability and Osteoarthritis Outcome Score (Hip)

    Assesses hip-related pain, symptoms, activities of daily living, and QoL across five subscales.

    Hip Disability and Osteoarthritis Outcome Score (HOOS), subscale scores transformed to a 0-100 scale, where higher scores indicate better hip-related health (less pain, fewer symptoms, better function, better quality of life).

    Measured: 3 months

  11. Knee Injury and Osteoarthritis Outcome Score (Knee)

    Measures knee-related outcomes across five domains, including pain, symptoms, activities of daily living, and QoL

    Knee Injury and Osteoarthritis Outcome Score (KOOS), subscale scores transformed to a 0-100 scale, where higher scores indicate better knee-related health (less pain, fewer symptoms, better function, better quality of life).

    Measured: 3 months

  12. Work Ability Index

    A 10-item questionnaire evaluating current work ability compared with the lifetime best, considering physical and mental demands and the impact of existing diseases

    Work Ability Index (WAI), total score range 7-49 points, where higher scores indicate better work ability (7 = very poor work ability, 49 = excellent work ability).

    Measured: 3 months

  13. Medication Quantification Scale (Version III)

    A validated tool to quantify the overall burden of pain medication based on pharmacological class, risk, and dose

    Medication Quantification Scale (Version III), total score is an open-ended numeric value calculated by summing weighted scores for each pain medication; higher scores indicate a higher overall medication burden and greater potential detriment (worse outcome).

    Measured: 3 months

  14. Pain Self-Efficacy Questionnaire

    Measures a patient's confidence in performing daily activities despite pain (10 items, scored 0 to 6)

    Pain Self-Efficacy Questionnaire (PSEQ), total score range 0-60, where higher scores indicate better pain self-efficacy (greater confidence in functioning and managing daily activities despite pain).

    Measured: 3 months

  15. Tampa Scale for Kinesiophobia (11 items)

    Tampa Scale for Kinesiophobia (TSK-11), total score range 11-44, where higher scores indicate greater kinesiophobia (more fear of movement/(re)injury and stronger fear-avoidance beliefs).

    Measured: 3 months

  16. EuroQol 5 Dimensions, 5 Levels

    A standardized instrument measuring general health status across five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression

    EuroQol 5 Dimensions, 5 Levels (EQ-5D-5L), reported as a health state profile plus an index and a VAS: health states are coded from 11111-55555 and converted to a country-specific index value (typically ranging from negative values up to 1, where 1 indicates full health), and the EQ VAS ranges from 0-100 with higher scores indicating better self-rated health.

    Measured: 3 months

  17. Patient-Reported Outcomes Measurement Information System - 29 items

    Evaluates seven health domains, including physical function, anxiety, fatigue, and sleep disturbance

    Patient-Reported Outcomes Measurement Information System - 29 items (PROMIS-29 Profile), domain scores are converted to T-scores with a mean of 50 and standard deviation of 10 in the reference population; higher T-scores indicate more of the domain being measured (e.g. higher = worse for anxiety, depression, pain interference, fatigue and sleep disturbance; higher = better for physical function and participation in social roles).

    Measured: 3 months

  18. Brief Pain Inventory

    Assesses both pain severity (scale 0-10) and the interference of pain with daily activities

    Brief Pain Inventory (BPI), pain severity and pain interference scores each range from 0-10 (derived as the mean of 0-10 item ratings), where higher scores indicate worse pain intensity and greater pain-related interference with daily functioning.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Dec 2025
  2. Study start1 Jul 2026 (estimated)
  3. Primary completion1 May 2030 (estimated)
  4. Study completion1 Aug 2031 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07289984
Sponsor's protocol ID
UniversitairZB25428
Other IDs
25428
Acronym
CRYONIC
Status last verified
Nov 2025
First submitted
4 Dec 2025
Last updated
27 Apr 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing cryoablation in people with Chronic Musculoskeletal Pain and Cryo Analgesia, run by Universitair Ziekenhuis Brussel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 27 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Numeric Rating Scale (NRS) (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Apr 2026; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in